Global humanized mice model market is projected to grow at a CAGR of more than 10% during 2020 - 2025. The global humanized mice model market is driven by continuous research and development activities in pharmaceutical companies across the globe. In addition to this, increasing investments for research in laboratories and institutes is positively impacting the growth of market.

The global humanized mice model market is segmented based on service, type, immune checkpoints, application, end user, and region. Based on type, the market is fragmented into cell line transplantation model, patient derived xenografts, genetically engineered mouse model and others. Out of these segments, the cell transplantation model segment dominated the market until 2019 and is expected to maintain its lead in the market during the forecast period as well. This is mainly, due to the ongoing investments in the development of new and innovative knockout models.

Based on the application, the market is segmented into immune-oncology, central nervous system, cardiovascular, diabetes and others. The immune-oncology segment accounted for the largest market share in 2019 and the segment is expected to maintain its market dominance during the forecast period as well due to the growing rate of cancer cases and increasing investments on immune-oncology research.

Major players operating in the global humanized mice model market include Charles River Laboratories, International, Inc., The Jackson Laboratory, Gempharmatech Co Ltd, Taconic Biosciences, Inc., Envigo (Harlan Laboratories, Inc.), Laboratory Corporation of America Holdings, Janvier Labs, Trans Genic, Inc., Genoway, Creative Biolabd, Horizon Discovery Group, Ingenious Targeting Laboratory, Biocytogen, Taconic Biosciences and others.

Years considered for this report:

Historical Years: 2015 - 2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021 - 2025

Objective of the Study:

  • To analyze and estimate the market size of global humanized mice model market from 2015 to 2018.
  • To estimate and forecast the market size of global humanized mice model market from 2019 to 2025.
  • To classify and forecast global humanized mice model market based on service, type, immune checkpoints, service, application, end use, company and regional distribution.
  • To identify dominant region or segment in the global humanized mice model market.
  • To identify drivers and challenges for global humanized mice model market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global humanized mice model market.
  • To conduct pricing analysis for global humanized mice model market.
  • To identify and analyze the profile of leading players operating in global humanized mice model market.
  • To identify key sustainable strategies adopted by market players in global humanized mice model market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of research labs/ institutes across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the research labs/ institutes which could not be identified due to the limitations of secondary research. TechSci Research analyzed the research labs/ institutes and presence of all major players across the globe.

TechSci Research calculated the market size of global humanized mice model market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Humanized mice model research labs/institutes, end users and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to humanized mice model
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as research labs/institutes, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global humanized mice model market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Service:
    • Breeding
    • Model In-Licensing
    • Genetic Testing
    • Other Services
  • Market, By Type:
    • Cell-line transplantation model
    • Patient derived xenografts
    • Genetically Engineered Mice
    • Others
  • Market, By Immune Checkpoints:
    • CTLA-4
    • CD39
    • PD-1/  
    • Others
  • Market, By Application:
    • Immuno-oncology
    • Diabetes Studies
    • Cardiovascular Studies
    • Central Nervous System (CNS) Studies
    • Other Type Studies
  • Market, By End-Use:
    • Companies {Pharmaceutical, BioService, Cosmetics}
    • Academic and Research Institutes
    • Contract Research Organizations
  • Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia & CIS
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Rest of World

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global humanized mice model market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Humanized Mice Model Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Humanized Mice Model Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Service (Breeding, Model In-Licensing, Genetic Testing, Other Services)

6.2.2.     By Type (Cell-line transplantation model, Patient based xenografts, Genetically Engineered Mice, Others)

6.2.3.     By Immune Checkpoints (PD-1, CTLA-4, CD-39, Others)

6.2.4.     By Application (Immuno-Oncology Studies, Diabetes Studies, Cardiovascular Studies, Central Nervous System (CNS) Studies, Other Type Studies)

6.2.5.     By End-user (Companies {Pharmaceutical, BioService, Academic and Research Institutes, Contract Research Organizations)

6.2.6.     By Company

6.2.7.     By Region

6.3.  Market Attractiveness Index

7.    Asia-Pacific Humanized Mice Model Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Service

7.2.2.     By Type

7.2.3.     By Application

7.2.4.     By Immune Check Points

7.2.5.     By End User

7.2.6.     By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Mice Humanized Model Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Service

7.3.1.2.2.             By Type

7.3.1.2.3.             By Application

7.3.1.2.4.             By End User

7.3.2.     India Humanized Mice Model Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Service

7.3.2.2.2.             By Type

7.3.2.2.3.             By Application

7.3.2.2.4.             By End User

7.3.3.     Australia Humanized Mice Model Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Service

7.3.3.2.2.             By Type

7.3.3.2.3.             By Application

7.3.3.2.4.             By End User

7.3.4.     Japan Humanized Mice Model Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Service

7.3.4.2.2.             By Type

7.3.4.2.3.             By Application

7.3.4.2.4.             By End User

7.3.5.     South Korea Humanized Mice Model Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Service

7.3.5.2.2.             By Type

7.3.5.2.3.             By Application

7.3.5.2.4.             By End User

8.    Europe Humanized Mice Model Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Service

8.2.2.     By Type

8.2.3.     By Application

8.2.4.     By Immune Check Points

8.2.5.     By End User

8.2.6.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Humanized Mice Model Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Service

8.3.1.2.2.             By Type

8.3.1.2.3.             By Application

8.3.1.2.4.             By End User

8.3.2.     Germany Humanized Mice Model Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Service

8.3.2.2.2.             By Type

8.3.2.2.3.             By Application

8.3.2.2.4.             By End User

8.3.3.     United Kingdom Humanized Mice Model Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Service

8.3.3.2.2.             By Type

8.3.3.2.3.             By Application

8.3.3.2.4.             By End Use

8.3.4.     Italy Humanized Mice Model Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Service

8.3.4.2.2.             By Type

8.3.4.2.3.             By Application

8.3.4.2.4.             By End User

8.3.5.     Spain Humanized Mice Model Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Service

8.3.5.2.2.             By Type

8.3.5.2.3.             By Application

8.3.5.2.4.             By End User

8.3.6.     Russia & CIS Humanized Mice Model Market Outlook

8.3.6.1.         Market Size & Forecast

8.3.6.1.1.             By Value

8.3.6.2.         Market Share & Forecast

8.3.6.2.1.             By Service

8.3.6.2.2.             By Type

8.3.6.2.3.             By Application

8.3.6.2.4.             By End User

9.    North America Humanized Mice Model Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Service

9.2.2.     By Type

9.2.3.     By Application

9.2.4.     By Immune Check Points

9.2.5.     By End User

9.2.6.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Humanized Mice Model Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Service

9.3.1.2.2.             By Type

9.3.1.2.3.             By Application

9.3.1.2.4.             By End User

9.3.2.     Mexico Mice Humanized Model Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Service

9.3.2.2.2.             By Type

9.3.2.2.3.             By Application

9.3.2.2.4.             By End User

9.3.3.     Canada Mice Humanized Model Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Service

9.3.3.2.2.             By Type

9.3.3.2.3.             By Application

9.3.3.2.4.             By End User

10.  Rest of World Mice Humanized Model Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Service

10.2.2.  By Type

10.2.3.  By Application

10.2.4.  By Immune Check Points

10.2.5.  By End User

10.2.6.  By Country

10.3.              Rest of World: Country Analysis

10.3.1.  Brazil Humanized Mice Model Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Service

10.3.1.2.2.           By Type

10.3.1.2.3.           By Application

10.3.1.2.4.           By End User

10.3.2.  South Africa Humanized Mice Model Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Service

10.3.2.2.2.           By Type

10.3.2.2.3.           By Application

10.3.2.2.4.           By End User

10.3.3.  Israel Humanized Mice Model Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Service

10.3.3.2.2.           By Type

10.3.3.2.3.           By Application

10.3.3.2.4